Global Action Plan For Health: Addressing Determinants Of Health Key To SDG Progress 11/07/2019 David Branigan A new plan to improve collaboration across 12 United Nations and multilateral agencies to support UN member states to reach 2030 targets on health includes not only the ambitious aim of reducing bureaucracy and increasing efficiency, but of working better across sectors to address environmental, commercial and social factors that harm health. These factors, which […] Continue reading -> Resolutions To Combat Childhood Marriage and Increase Access to Medicines Approved by UN Human Rights Council 11/07/2019 Elaine Ruth Fletcher A UN Human Rights Council resolution calling for countries to combat childhood, early and forced marriages, and supported by over 60 UN member states, ran into heavy criticism today prior to its final approval. A number of countries in the Middle East, South-East Asia and North Africa publicly disassociated themselves from clauses promoting girls access […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> New Cancer Drugs Top Entries On WHO Essential Medicines List 09/07/2019 Editorial team, Elaine Ruth Fletcher & David Branigan WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and public health systems. The addition of major new cancer treatments in five categories, melanoma (skin), lung, blood and prostate cancers, reflects […] Continue reading -> Community & Health Sector Cooperation Contains Ebola Threat In Uganda; Epidemic Simmers On In DRC 08/07/2019 Maina Waruru Nairobi, Kenya – The World Health Organization has commended efforts by the government of Uganda for keeping the deadly Ebola virus from spreading eastwards into the country from the Democratic Republic of the Congo (DRC), where a prolonged outbreak has claimed approximately 1,600 lives since last August. The East African country has recorded only three […] Continue reading -> Who should lead UNAIDS? 05/07/2019 Guest contributor [Republished from The Lancet] Richard Horton, Editor-in-Chief of The Lancet, examines the issues around the pending appointment of a new executive director for UNAIDS, as well as the candidates for the post, following the May resignation of executive director Michel Sidibé. The selection process has fueled questions about who may now be best positioned to […] Continue reading -> “Delinkage” Of Medicines R&D From Patent Incentives Stirs Debate at Human Rights Council 04/07/2019 Elaine Ruth Fletcher Only a month after a hotly-contested World Health Assembly resolution touched off a debate around “price transparency” as a way to improve access to medicines, a new controversy over how to stimulate access has emerged in another UN Forum, the Human Rights Council. This time the debate is around ways to “delink” incentives for the […] Continue reading -> EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> GARDP To Develop & Deliver 5 New Treatments For Antibiotic Resistant Infections By 2025 04/07/2019 David Branigan The Global Antibiotic Research & Development Partnership (GARDP) has announced its new “5 BY 25” strategy to mobilise global stakeholders to raise the €500 million needed to develop and deliver five new antibiotic treatments by 2025, to help tackle antimicrobial resistance (AMR). Drug-resistant infections already cause at least 700,000 deaths globally each year, and affect […] Continue reading -> Climate Is A ‘Well-Being’ Issue; OECD Head Decries Lack Of Political Action 03/07/2019 Elaine Ruth Fletcher Globally, political resistance to assertive climate action remains an enormous barrier to change, despite mounting evidence about the impacts of climate change on people’s well-being and health, said Angel Gurria, secretary general of the Organisation of Economic Co-operation and Development (OECD), before an audience of several hundred people in Geneva today. Reframing the climate debate […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Resolutions To Combat Childhood Marriage and Increase Access to Medicines Approved by UN Human Rights Council 11/07/2019 Elaine Ruth Fletcher A UN Human Rights Council resolution calling for countries to combat childhood, early and forced marriages, and supported by over 60 UN member states, ran into heavy criticism today prior to its final approval. A number of countries in the Middle East, South-East Asia and North Africa publicly disassociated themselves from clauses promoting girls access […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> New Cancer Drugs Top Entries On WHO Essential Medicines List 09/07/2019 Editorial team, Elaine Ruth Fletcher & David Branigan WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and public health systems. The addition of major new cancer treatments in five categories, melanoma (skin), lung, blood and prostate cancers, reflects […] Continue reading -> Community & Health Sector Cooperation Contains Ebola Threat In Uganda; Epidemic Simmers On In DRC 08/07/2019 Maina Waruru Nairobi, Kenya – The World Health Organization has commended efforts by the government of Uganda for keeping the deadly Ebola virus from spreading eastwards into the country from the Democratic Republic of the Congo (DRC), where a prolonged outbreak has claimed approximately 1,600 lives since last August. The East African country has recorded only three […] Continue reading -> Who should lead UNAIDS? 05/07/2019 Guest contributor [Republished from The Lancet] Richard Horton, Editor-in-Chief of The Lancet, examines the issues around the pending appointment of a new executive director for UNAIDS, as well as the candidates for the post, following the May resignation of executive director Michel Sidibé. The selection process has fueled questions about who may now be best positioned to […] Continue reading -> “Delinkage” Of Medicines R&D From Patent Incentives Stirs Debate at Human Rights Council 04/07/2019 Elaine Ruth Fletcher Only a month after a hotly-contested World Health Assembly resolution touched off a debate around “price transparency” as a way to improve access to medicines, a new controversy over how to stimulate access has emerged in another UN Forum, the Human Rights Council. This time the debate is around ways to “delink” incentives for the […] Continue reading -> EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> GARDP To Develop & Deliver 5 New Treatments For Antibiotic Resistant Infections By 2025 04/07/2019 David Branigan The Global Antibiotic Research & Development Partnership (GARDP) has announced its new “5 BY 25” strategy to mobilise global stakeholders to raise the €500 million needed to develop and deliver five new antibiotic treatments by 2025, to help tackle antimicrobial resistance (AMR). Drug-resistant infections already cause at least 700,000 deaths globally each year, and affect […] Continue reading -> Climate Is A ‘Well-Being’ Issue; OECD Head Decries Lack Of Political Action 03/07/2019 Elaine Ruth Fletcher Globally, political resistance to assertive climate action remains an enormous barrier to change, despite mounting evidence about the impacts of climate change on people’s well-being and health, said Angel Gurria, secretary general of the Organisation of Economic Co-operation and Development (OECD), before an audience of several hundred people in Geneva today. Reframing the climate debate […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> New Cancer Drugs Top Entries On WHO Essential Medicines List 09/07/2019 Editorial team, Elaine Ruth Fletcher & David Branigan WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and public health systems. The addition of major new cancer treatments in five categories, melanoma (skin), lung, blood and prostate cancers, reflects […] Continue reading -> Community & Health Sector Cooperation Contains Ebola Threat In Uganda; Epidemic Simmers On In DRC 08/07/2019 Maina Waruru Nairobi, Kenya – The World Health Organization has commended efforts by the government of Uganda for keeping the deadly Ebola virus from spreading eastwards into the country from the Democratic Republic of the Congo (DRC), where a prolonged outbreak has claimed approximately 1,600 lives since last August. The East African country has recorded only three […] Continue reading -> Who should lead UNAIDS? 05/07/2019 Guest contributor [Republished from The Lancet] Richard Horton, Editor-in-Chief of The Lancet, examines the issues around the pending appointment of a new executive director for UNAIDS, as well as the candidates for the post, following the May resignation of executive director Michel Sidibé. The selection process has fueled questions about who may now be best positioned to […] Continue reading -> “Delinkage” Of Medicines R&D From Patent Incentives Stirs Debate at Human Rights Council 04/07/2019 Elaine Ruth Fletcher Only a month after a hotly-contested World Health Assembly resolution touched off a debate around “price transparency” as a way to improve access to medicines, a new controversy over how to stimulate access has emerged in another UN Forum, the Human Rights Council. This time the debate is around ways to “delink” incentives for the […] Continue reading -> EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> GARDP To Develop & Deliver 5 New Treatments For Antibiotic Resistant Infections By 2025 04/07/2019 David Branigan The Global Antibiotic Research & Development Partnership (GARDP) has announced its new “5 BY 25” strategy to mobilise global stakeholders to raise the €500 million needed to develop and deliver five new antibiotic treatments by 2025, to help tackle antimicrobial resistance (AMR). Drug-resistant infections already cause at least 700,000 deaths globally each year, and affect […] Continue reading -> Climate Is A ‘Well-Being’ Issue; OECD Head Decries Lack Of Political Action 03/07/2019 Elaine Ruth Fletcher Globally, political resistance to assertive climate action remains an enormous barrier to change, despite mounting evidence about the impacts of climate change on people’s well-being and health, said Angel Gurria, secretary general of the Organisation of Economic Co-operation and Development (OECD), before an audience of several hundred people in Geneva today. Reframing the climate debate […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Cancer Drugs Top Entries On WHO Essential Medicines List 09/07/2019 Editorial team, Elaine Ruth Fletcher & David Branigan WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and public health systems. The addition of major new cancer treatments in five categories, melanoma (skin), lung, blood and prostate cancers, reflects […] Continue reading -> Community & Health Sector Cooperation Contains Ebola Threat In Uganda; Epidemic Simmers On In DRC 08/07/2019 Maina Waruru Nairobi, Kenya – The World Health Organization has commended efforts by the government of Uganda for keeping the deadly Ebola virus from spreading eastwards into the country from the Democratic Republic of the Congo (DRC), where a prolonged outbreak has claimed approximately 1,600 lives since last August. The East African country has recorded only three […] Continue reading -> Who should lead UNAIDS? 05/07/2019 Guest contributor [Republished from The Lancet] Richard Horton, Editor-in-Chief of The Lancet, examines the issues around the pending appointment of a new executive director for UNAIDS, as well as the candidates for the post, following the May resignation of executive director Michel Sidibé. The selection process has fueled questions about who may now be best positioned to […] Continue reading -> “Delinkage” Of Medicines R&D From Patent Incentives Stirs Debate at Human Rights Council 04/07/2019 Elaine Ruth Fletcher Only a month after a hotly-contested World Health Assembly resolution touched off a debate around “price transparency” as a way to improve access to medicines, a new controversy over how to stimulate access has emerged in another UN Forum, the Human Rights Council. This time the debate is around ways to “delink” incentives for the […] Continue reading -> EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> GARDP To Develop & Deliver 5 New Treatments For Antibiotic Resistant Infections By 2025 04/07/2019 David Branigan The Global Antibiotic Research & Development Partnership (GARDP) has announced its new “5 BY 25” strategy to mobilise global stakeholders to raise the €500 million needed to develop and deliver five new antibiotic treatments by 2025, to help tackle antimicrobial resistance (AMR). Drug-resistant infections already cause at least 700,000 deaths globally each year, and affect […] Continue reading -> Climate Is A ‘Well-Being’ Issue; OECD Head Decries Lack Of Political Action 03/07/2019 Elaine Ruth Fletcher Globally, political resistance to assertive climate action remains an enormous barrier to change, despite mounting evidence about the impacts of climate change on people’s well-being and health, said Angel Gurria, secretary general of the Organisation of Economic Co-operation and Development (OECD), before an audience of several hundred people in Geneva today. Reframing the climate debate […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Community & Health Sector Cooperation Contains Ebola Threat In Uganda; Epidemic Simmers On In DRC 08/07/2019 Maina Waruru Nairobi, Kenya – The World Health Organization has commended efforts by the government of Uganda for keeping the deadly Ebola virus from spreading eastwards into the country from the Democratic Republic of the Congo (DRC), where a prolonged outbreak has claimed approximately 1,600 lives since last August. The East African country has recorded only three […] Continue reading -> Who should lead UNAIDS? 05/07/2019 Guest contributor [Republished from The Lancet] Richard Horton, Editor-in-Chief of The Lancet, examines the issues around the pending appointment of a new executive director for UNAIDS, as well as the candidates for the post, following the May resignation of executive director Michel Sidibé. The selection process has fueled questions about who may now be best positioned to […] Continue reading -> “Delinkage” Of Medicines R&D From Patent Incentives Stirs Debate at Human Rights Council 04/07/2019 Elaine Ruth Fletcher Only a month after a hotly-contested World Health Assembly resolution touched off a debate around “price transparency” as a way to improve access to medicines, a new controversy over how to stimulate access has emerged in another UN Forum, the Human Rights Council. This time the debate is around ways to “delink” incentives for the […] Continue reading -> EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> GARDP To Develop & Deliver 5 New Treatments For Antibiotic Resistant Infections By 2025 04/07/2019 David Branigan The Global Antibiotic Research & Development Partnership (GARDP) has announced its new “5 BY 25” strategy to mobilise global stakeholders to raise the €500 million needed to develop and deliver five new antibiotic treatments by 2025, to help tackle antimicrobial resistance (AMR). Drug-resistant infections already cause at least 700,000 deaths globally each year, and affect […] Continue reading -> Climate Is A ‘Well-Being’ Issue; OECD Head Decries Lack Of Political Action 03/07/2019 Elaine Ruth Fletcher Globally, political resistance to assertive climate action remains an enormous barrier to change, despite mounting evidence about the impacts of climate change on people’s well-being and health, said Angel Gurria, secretary general of the Organisation of Economic Co-operation and Development (OECD), before an audience of several hundred people in Geneva today. Reframing the climate debate […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Who should lead UNAIDS? 05/07/2019 Guest contributor [Republished from The Lancet] Richard Horton, Editor-in-Chief of The Lancet, examines the issues around the pending appointment of a new executive director for UNAIDS, as well as the candidates for the post, following the May resignation of executive director Michel Sidibé. The selection process has fueled questions about who may now be best positioned to […] Continue reading -> “Delinkage” Of Medicines R&D From Patent Incentives Stirs Debate at Human Rights Council 04/07/2019 Elaine Ruth Fletcher Only a month after a hotly-contested World Health Assembly resolution touched off a debate around “price transparency” as a way to improve access to medicines, a new controversy over how to stimulate access has emerged in another UN Forum, the Human Rights Council. This time the debate is around ways to “delink” incentives for the […] Continue reading -> EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> GARDP To Develop & Deliver 5 New Treatments For Antibiotic Resistant Infections By 2025 04/07/2019 David Branigan The Global Antibiotic Research & Development Partnership (GARDP) has announced its new “5 BY 25” strategy to mobilise global stakeholders to raise the €500 million needed to develop and deliver five new antibiotic treatments by 2025, to help tackle antimicrobial resistance (AMR). Drug-resistant infections already cause at least 700,000 deaths globally each year, and affect […] Continue reading -> Climate Is A ‘Well-Being’ Issue; OECD Head Decries Lack Of Political Action 03/07/2019 Elaine Ruth Fletcher Globally, political resistance to assertive climate action remains an enormous barrier to change, despite mounting evidence about the impacts of climate change on people’s well-being and health, said Angel Gurria, secretary general of the Organisation of Economic Co-operation and Development (OECD), before an audience of several hundred people in Geneva today. Reframing the climate debate […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
“Delinkage” Of Medicines R&D From Patent Incentives Stirs Debate at Human Rights Council 04/07/2019 Elaine Ruth Fletcher Only a month after a hotly-contested World Health Assembly resolution touched off a debate around “price transparency” as a way to improve access to medicines, a new controversy over how to stimulate access has emerged in another UN Forum, the Human Rights Council. This time the debate is around ways to “delink” incentives for the […] Continue reading -> EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> GARDP To Develop & Deliver 5 New Treatments For Antibiotic Resistant Infections By 2025 04/07/2019 David Branigan The Global Antibiotic Research & Development Partnership (GARDP) has announced its new “5 BY 25” strategy to mobilise global stakeholders to raise the €500 million needed to develop and deliver five new antibiotic treatments by 2025, to help tackle antimicrobial resistance (AMR). Drug-resistant infections already cause at least 700,000 deaths globally each year, and affect […] Continue reading -> Climate Is A ‘Well-Being’ Issue; OECD Head Decries Lack Of Political Action 03/07/2019 Elaine Ruth Fletcher Globally, political resistance to assertive climate action remains an enormous barrier to change, despite mounting evidence about the impacts of climate change on people’s well-being and health, said Angel Gurria, secretary general of the Organisation of Economic Co-operation and Development (OECD), before an audience of several hundred people in Geneva today. Reframing the climate debate […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database 04/07/2019 David Branigan The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database. The open letter by the European Commission (EC), the European Medicines Agency […] Continue reading -> GARDP To Develop & Deliver 5 New Treatments For Antibiotic Resistant Infections By 2025 04/07/2019 David Branigan The Global Antibiotic Research & Development Partnership (GARDP) has announced its new “5 BY 25” strategy to mobilise global stakeholders to raise the €500 million needed to develop and deliver five new antibiotic treatments by 2025, to help tackle antimicrobial resistance (AMR). Drug-resistant infections already cause at least 700,000 deaths globally each year, and affect […] Continue reading -> Climate Is A ‘Well-Being’ Issue; OECD Head Decries Lack Of Political Action 03/07/2019 Elaine Ruth Fletcher Globally, political resistance to assertive climate action remains an enormous barrier to change, despite mounting evidence about the impacts of climate change on people’s well-being and health, said Angel Gurria, secretary general of the Organisation of Economic Co-operation and Development (OECD), before an audience of several hundred people in Geneva today. Reframing the climate debate […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
GARDP To Develop & Deliver 5 New Treatments For Antibiotic Resistant Infections By 2025 04/07/2019 David Branigan The Global Antibiotic Research & Development Partnership (GARDP) has announced its new “5 BY 25” strategy to mobilise global stakeholders to raise the €500 million needed to develop and deliver five new antibiotic treatments by 2025, to help tackle antimicrobial resistance (AMR). Drug-resistant infections already cause at least 700,000 deaths globally each year, and affect […] Continue reading -> Climate Is A ‘Well-Being’ Issue; OECD Head Decries Lack Of Political Action 03/07/2019 Elaine Ruth Fletcher Globally, political resistance to assertive climate action remains an enormous barrier to change, despite mounting evidence about the impacts of climate change on people’s well-being and health, said Angel Gurria, secretary general of the Organisation of Economic Co-operation and Development (OECD), before an audience of several hundred people in Geneva today. Reframing the climate debate […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Climate Is A ‘Well-Being’ Issue; OECD Head Decries Lack Of Political Action 03/07/2019 Elaine Ruth Fletcher Globally, political resistance to assertive climate action remains an enormous barrier to change, despite mounting evidence about the impacts of climate change on people’s well-being and health, said Angel Gurria, secretary general of the Organisation of Economic Co-operation and Development (OECD), before an audience of several hundred people in Geneva today. Reframing the climate debate […] Continue reading -> Posts navigation Older postsNewer posts